FinlaysonS. R. G. and BirkmeyerJ. D., Cost-effectiveness analysis in surgery. Surgery, 1998, 123, 151–156.
2.
SandisonA. J. P., WoodC. H., PadayacheeT. S., Cost effective carotid endarterectomy. British Journal of Surgery, 2000, 87, 323–327.
3.
KentK. C., KuntzK. M., PatelM. R., Peri-operative imaging strategies for carotid endarterectomy: an analysis of morbidity and cost-effectiveness in symptomatic patients. Journal of the American Medical Association, 1995, 274, 888–893.
4.
MartinJ. D., ValentineR. J., MyersD. I., Is routine scanning necessary in the pre-operative evaluation of patients undergoing carotid endarterectomy?Journal of Vascular Surgery, 1991, 14, 267–270.
5.
NaylorA. R., JohnT., HowlettJ., Serial surveillance imaging does not alter clinical outcome following carotid endarterectomy. British Journal of Surgery, 1996, 83, 522–526.
6.
PatelS. T., KuntzK. M. and KentK. C., Is routine duplex ultrasound surveillance after carotid endarterectomy cost-effective?Surgery, 1998, 124, 343–351.
7.
NaylorA. R. and RothwellP., Should cost-effectiveness influence patient selection for carotid surgery? In Carotid Artery Surgery; A Problem-based Approach, eds NaylorA. R. and MacKeyW. C.. W. B. Saunders, London, 2000, pp. 66–71.
8.
CronenwettJ. L. and BirkmeyerJ. D., Should cost-effectiveness influence patient selection for carotid surgery? In Carotid Artery Surgery: A Problem-based Approach, eds NaylorA. R.MacKeyW. C., Saunders W. B., London, 2000, pp. 73–81.
9.
CronenwettJ. L., BirkmeyerJ. D., NackmanG. B., Cost-effectiveness of carotid endarterectomy in asymptomatic patients. Journal of Vascular Surgery, 1997, 25, 298–309.
10.
Anon, Management of Peripheral Arterial Disease (PAD). TransAtlantic Inter-Society Consensus (TASC). European Journal of Vascular and Endovascular Surgery, 2000, 19(Suppl. A), S1–S250.
11.
RudofskyG. and van LaakH. H., Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy. Journal of Cardiovascular Pharmacology, 1994, 23(Suppl. 3), S22–S25.
12.
LebrunT., SelkeB., SaillyJ. C., The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socio-economic consequences of peripheral occlusive arterial disease of the lower limbs. Journal of Cardiovascular Pharmacology, 1994, 23(Suppl. 3), S17–S21.
13.
BoschJ. L., TetterooE., MaliW. P., Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement and PTA Dutch Stent Trial Study Group. Radiology, 1998, 208, 641–648.
14.
CAPRIE Steering Committee, A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1996, 348, 1329–1339.
15.
GoldmanL., WeinsteinM. C., GoldmanP. A., Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA, 1991, 265, 1145–1151.
16.
KaulA., Pharmacoeconomic considerations in peripheral arterial thrombolytic therapy. Journal of Vascular and Interventional Radiology, 1995, 6, S104–S110.
17.
HochJ. R., TullisM. J., ArcherC. W., Thrombolysis versus surgery as the initial management for native artery occlusion: efficacy, safety, and cost, Surgery, 1994, 16, 649–657.
18.
BallardJ. L., BerganJ. J., SinghP., Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. Journal of Vascular Surgery, 1998, 28 (1), 94–101.
19.
PanayiotopoulosY. P., TyrrellM. R., OwenS. E., Outcome and cost analysis after femorocrural and femoropedal grafting for lower limb-threatening ischaemia. British Journal of Surgery, 1997, 84, 207–212.
20.
SinghS., EvensL., DattaD., The costs of managing lower limb-threatening ischaemia. European Journal of Surgery, 1996, 12, 359–362.
21.
HuninkM. G., CullenK. A. and DonaldsonM. C., Hospital costs of revascularisation procedures for femoropopliteal arterial disease. Journal of Vascular Surgery, 1994, 19, 632–641.
CheshireN., WolfeJ., NooneM., The economics of femorocrural reconstruction for critical leg ischaemia with and without autologous vein. Journal of Vascular Surgery, 1992, 15, 167–175.
24.
SchemerhornM. I., BirkmeyerJ. D., GouldD. A., Cost-effectiveness of surgery for small abdominal aortic aneurysms on the basis of data from the United Kingdom small aneurysm trial. Journal of Vascular Surgery, 2000, 31, 217–226.
25.
Anon, The UK Small Aneurysm Trial Participants: mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet, 1998, 352, 1649–1655.
26.
GlanceL. G., Selective preoperative cardiac screening improves five-year survival in patients undergoing major vascular surgery: a cost effective analysis. Journal of Cardiovascular and Vascular Anaesthesia, 1999, 13, 265–271.
27.
ThomasS. M., CalvertN. W., GainesP. A., How cost-effective is endovascular repair of abdominal aortic aneurysm (AAA) vs. conventional open repair in fit patients? — An approach using modelling techniques. Abstract presented at the British Society of Interventional Radiology, Newcastle upon Tyne Nov 2000, Abstract booklet p. 25.
28.
PatelS. T., HaserP. B., BushH. L.Jr., The cost-effectiveness of endovascular repair vs open surgical repair of abdominal aorta aneurysms; a decision analysis model. Journal of Vascular Surgery, 1999, 29, 958–972.
29.
LaheijR. J. F., ButhJ., HarrisP. L., Need for secondary interventions after endovascular repair of abdominal aortic aneurysms: intermediate-term follow-up of a European collaborative registry (EUROSTAR). British Journal of Surgery, 2000, 87, 1666–1673.
30.
PatelS. T., KornP., HaserP. B., The cost-effectiveness of repairing ruptured abdominal aorta aneurysms. Journal of Vascular Surgery, 2000, 32, 247–257.